Your browser doesn't support javascript.
loading
Fludarabine, cyclophosphamide, and rituximab treatment achieves long-term disease-free survival in IGHV-mutated chronic lymphocytic leukemia.
Thompson, Philip A; Tam, Constantine S; O'Brien, Susan M; Wierda, William G; Stingo, Francesco; Plunkett, William; Smith, Susan C; Kantarjian, Hagop M; Freireich, Emil J; Keating, Michael J.
Afiliação
  • Thompson PA; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX;
  • Tam CS; Department of Haematology and Medical Oncology, Peter MacCallum Cancer Center, Melbourne, Australia;
  • O'Brien SM; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX;
  • Wierda WG; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX;
  • Stingo F; Department of Biostatistics, and.
  • Plunkett W; Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX.
  • Smith SC; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX;
  • Kantarjian HM; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX;
  • Freireich EJ; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX;
  • Keating MJ; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX;
Blood ; 127(3): 303-9, 2016 Jan 21.
Article em En | MEDLINE | ID: mdl-26492934

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica / Cadeias Pesadas de Imunoglobulinas / Mutação Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica / Cadeias Pesadas de Imunoglobulinas / Mutação Idioma: En Ano de publicação: 2016 Tipo de documento: Article